{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:03:39Z","timestamp":1774364619180,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.clinthera.2023.09.004","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:25:23Z","timestamp":1695921923000},"page":"1137-1141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Compatibility of Omadacycline With Select Parenteral Products in Simulated Y-site Administration"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0528-771X","authenticated-orcid":false,"given":"David A.","family":"Butler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Moolick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donavon","family":"McCray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxwell","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.09.004_sbref0001","series-title":"HCUP Statistical Brief #277","article-title":"Most Frequent Principal Diagnoses for Inpatient Stays in U.S. Hospitals, 2018","author":"McDermott","year":"2021"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0002","unstructured":"Nuzyra (omadacycline) for Injection, for Intravenous Use [package insert]. Revised May 2021. Available at https:\/\/www.nuzyra.com\/nuzyra-pi.pdf. Accessed November 14, 2022."},{"key":"10.1016\/j.clinthera.2023.09.004_bib0003","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/cid\/ciz395","article-title":"Microbiology and Preclinical Review of Omadacycline","volume":"69","author":"Karlowsky","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00709-21","article-title":"Efficacy of omadacycline against multidrug-resistant Enterococcus faecium strains in a mouse peritonitis model","volume":"65","author":"Singh","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01135-17","article-title":"Comparison of omadacycline and tigecycline pharmacokinetics in the plasma, epithelial lining fluid, and alveolar cells of healthy adult subjects","volume":"61","author":"Gotfried","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0006","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/ciz309","article-title":"Pharmacokinetics and pharmacodynamics of oral and intravenous omadacycline","volume":"69","author":"Rodvold","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2023.09.004_sbref0007","series-title":"Multidiscipline Review Application Number 209816Orig1s000 and 209817Orig1s000","year":"2018"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0008","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/cid\/cix647","article-title":"Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality","volume":"65","author":"Ramirez","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0009","article-title":"Diabetes care in the hospital: standards of care in diabetes\u20142023","volume":"46","author":"Elsayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0010","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0011","article-title":"Medication Administration Errors","author":"MacDowell","year":"2021","journal-title":"AHRQ"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0012","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archinternmed.2010.65","article-title":"Association of interruptions with an increased risk and severity of medication administration errors","volume":"170","author":"Westbrook","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0013","unstructured":"Adult Continuous Infusion Standards. ASHP. Updated 2020. Available at: https:\/\/www.ashp.org\/-\/media\/assets\/pharmacy-practice\/s4s\/docs\/Adult-Infusion-Standards.pdf. Accessed November 14, 2022."},{"key":"10.1016\/j.clinthera.2023.09.004_bib0014","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.clinthera.2019.08.005","article-title":"Assessment of the physical compatibility of eravacycline and common parenteral drugs during simulated Y-site administration","volume":"41","author":"Avery","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0015","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2146\/ajhp170839","article-title":"Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration","volume":"75","author":"Asempa","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0016","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2146\/ajhp070574","article-title":"Compatibility of doripenem with other drugs during simulated Y-site administration","volume":"65","author":"Brammer","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0017","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.clinthera.2020.06.005","article-title":"Intravenous compatibility of ceftazidime-avibactam and aztreonam using simulated and actual Y-site administration","volume":"42","author":"O'Donnell","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0018","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2146\/ajhp150170","article-title":"Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations","volume":"73","author":"O'Donnell","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.clinthera.2023.09.004_sbref0019","series-title":"Estimating Turbidity (NTU) from Absorption Data. Sensus Technical Note (SEN-TN-0010)","author":"Goodner","year":"2009"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0020","unstructured":"Furosemide Injection, for Intravenous or Intramuscular Use [package insert]. Available at https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=421aa6d5-623b-4dc2-abd5-bb9e7765bf37. Accessed November 14, 2022."},{"key":"10.1016\/j.clinthera.2023.09.004_bib0021","article-title":"Trissel's 2 Clinical Pharmaceutics Database","year":"2015","journal-title":"Clinical Pharmacology"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000005357","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0023","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/CCM.0000000000005054","article-title":"Identifying high-risk subphenotypes and associated harms from delayed antibiotic orders and delivery","volume":"49","author":"Han","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0024","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/NCQ.0000000000000181","article-title":"Nursing strategies to increase medication safety in inpatient settings","volume":"31","author":"Bravo","year":"2016","journal-title":"J Nurs Care Qual"},{"key":"10.1016\/j.clinthera.2023.09.004_bib0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jopan.2022.05.078","article-title":"Nursing shortage creating patient safety concerns","volume":"37","author":"Ross","year":"2022","journal-title":"J Perianesth Nurs"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823003491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823003491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:02:52Z","timestamp":1758963772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823003491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0149291823003491"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.09.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compatibility of Omadacycline With Select Parenteral Products in Simulated Y-site Administration","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}